23 April 2022>: Clinical Research
Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions
Liying Han 1CEF , Guanyong He 1CDE , Yingjie Mei 2CD , Qing Yu 3BF , Minning Zhao 3BF , Fu Luo 4B , Guanxun Cheng 1AEG** , Wen Liang 3AE**DOI: 10.12659/MSM.935307
Med Sci Monit 2022; 28:e935307
Figure 3 Receiver operating characteristic (ROC) curves of the independent variables and combined model. ROC curves of magnetic resonance imaging parameters (A), prostate-specific antigen (PSA) indexes (B), and comparison of ROC curves between the combined model (PSA density [PSAD]+apparent diffusion coefficient [ADC]) and ADC, PSAD, and PI-RADS v2 (C) for prostate cancer diagnosis. (MedCalc 15.2.2, MedCalc Software Ltd).